Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2021 | Personalized medicine in NETs

Peter M. Anderson, MD, PhD , Cleveland Clinic, Cleveland, OH, talks on the development of personalized medicine approaches for patients with neuroendocrine tumors (NETs), and the importance of targeting unique, targetable somatic mutations as well as the potential of RNA cancer vaccines for patients with NETs. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.